{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:33:56Z","timestamp":1793223236915,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12634-9","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:00:25Z","timestamp":1787292025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epigenetic regulation of ovarian steroidogenesis in PCOS: HDAC inhibitors and short-chain fatty acids"],"prefix":"10.1007","volume":"53","author":[{"given":"Tanwi","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"4","key":"12634_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir C (2020) The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci 13(4):261. https:\/\/doi.org\/10.4103\/jhrs.JHRS_95_18","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"12634_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"issue":"6","key":"12634_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/humupd\/dmy022","volume":"24","author":"MA Skiba","year":"2018","unstructured":"Skiba MA, Islam RM, Bell RJ, Davis SR (2018) Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 24(6):694\u2013709. https:\/\/doi.org\/10.1093\/humupd\/dmy022","journal-title":"Hum Reprod Update"},{"issue":"2","key":"12634_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P et al (2014) Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. N Engl J Med 371(2):119\u2013129. https:\/\/doi.org\/10.1056\/NEJMoa1313517","journal-title":"N Engl J Med"},{"key":"12634_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119874042","author":"TM Barber","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S (2019) Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. https:\/\/doi.org\/10.1177\/1179558119874042","journal-title":"Clin Med Insights Reprod Health"},{"issue":"7","key":"12634_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","volume":"30","author":"O Osibogun","year":"2020","unstructured":"Osibogun O, Ogunmoroti O, Michos ED (2020) Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends Cardiovasc Med 30(7):399\u2013404. https:\/\/doi.org\/10.1016\/j.tcm.2019.08.010","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"12634_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11154-016-9326-7","volume":"16","author":"E Palioura","year":"2015","unstructured":"Palioura E, Diamanti-Kandarakis E (2015) Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Rev Endocr Metab Disord 16(4):365\u2013371. https:\/\/doi.org\/10.1007\/s11154-016-9326-7","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"12634_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M (2010) Epigenetic modifications and human disease. Nat Biotechnol 28(10):1057\u201368. https:\/\/doi.org\/10.1038\/nbt.1685","journal-title":"Nat Biotechnol"},{"issue":"12","key":"12634_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","volume":"29","author":"KA Walters","year":"2018","unstructured":"Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE (2018) New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends Endocrinol Metabolism 29(12):841\u2013852. https:\/\/doi.org\/10.1016\/j.tem.2018.08.005","journal-title":"Trends Endocrinol Metabolism"},{"issue":"2","key":"12634_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/rmb2.12371","volume":"20","author":"M Orisaka","year":"2021","unstructured":"Orisaka M, Miyazaki Y, Shirafuji A, Tamamura C, Tsuyoshi H, Tsang BK et al (2021) The role of pituitary gonadotropins and intraovarian regulators in follicle development: A mini-review. Reprod Med Biol 20(2):169\u2013175. https:\/\/doi.org\/10.1002\/rmb2.12371","journal-title":"Reprod Med Biol"},{"issue":"5","key":"12634_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA (2016) The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev 37(5):467\u2013520. https:\/\/doi.org\/10.1210\/er.2015-1104","journal-title":"Endocr Rev"},{"issue":"8","key":"12634_CR12","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS (2019) Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 3(8):1545\u20131573. https:\/\/doi.org\/10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"issue":"1","key":"12634_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1210\/jc.2005-1696","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP (2006) Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91(1):336\u201340. https:\/\/doi.org\/10.1210\/jc.2005-1696","journal-title":"J Clin Endocrinol Metab"},{"key":"12634_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8589318","author":"T Zuo","year":"2016","unstructured":"Zuo T, Zhu M, Xu W (2016) Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2016\/8589318","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"12634_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052734","volume":"22","author":"S Aboeldalyl","year":"2021","unstructured":"Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HED, Amer S (2021) The role of chronic inflammation in polycystic ovarian syndrome\u2014a systematic review and meta-analysis. Int J Mol Sci 22(5):2734. https:\/\/doi.org\/10.3390\/ijms22052734","journal-title":"Int J Mol Sci"},{"issue":"7","key":"12634_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4067\/s0034-98872017000700907","volume":"145","author":"CF Concha","year":"2017","unstructured":"Concha CF, Sir PT, Recabarren E, P\u00e9rez S (2017) F. Epigen\u00e9tica del s\u00edndrome de ovario poliqu\u00edstico. Rev Med Chil 145(7):907\u2013915. https:\/\/doi.org\/10.4067\/s0034-98872017000700907","journal-title":"Rev Med Chil"},{"issue":"7","key":"12634_CR17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/biomedicines10071689","volume":"10","author":"M Dvoran","year":"2022","unstructured":"Dvoran M, Nemcova L, Kalous J (2022) An Interplay between Epigenetics and Translation in Oocyte Maturation and Embryo Development: Assisted Reproduction Perspective. Biomedicines 10(7):1689. https:\/\/doi.org\/10.3390\/biomedicines10071689","journal-title":"Biomedicines"},{"issue":"2","key":"12634_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00404-025-08048-w","volume":"312","author":"Y Zhong","year":"2025","unstructured":"Zhong Y, Ding J, Xia F (2025) DNA methylation and its impact on ovarian steroidogenesis in women with polycystic ovary syndrome: insights from human and animal models. Arch Gynecol Obstet 312(2):363\u2013374. https:\/\/doi.org\/10.1007\/s00404-025-08048-w","journal-title":"Arch Gynecol Obstet"},{"key":"12634_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1399757","author":"X Yu","year":"2024","unstructured":"Yu X, Xu J, Song B, Zhu R, Liu J, Liu YF et al (2024) The role of epigenetics in women\u2019s reproductive health: the impact of environmental factors. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2024.1399757","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12634_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.111950","volume":"573","author":"J Chen","year":"2023","unstructured":"Chen J, Zhu Z, Xu S, Li J, Huang L, Tan W et al (2023) HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19\/miR-29a-3p\/NLRP3-mediated granulosa cell pyroptosis. Mol Cell Endocrinol 573:111950. https:\/\/doi.org\/10.1016\/j.mce.2023.111950","journal-title":"Mol Cell Endocrinol"},{"issue":"22","key":"12634_CR21","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.3390\/ijms21228460","volume":"21","author":"MY Kim","year":"2020","unstructured":"Kim MY, Yan B, Huang S, Qiu Y (2020) Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis. Int J Mol Sci 21(22):8460. https:\/\/doi.org\/10.3390\/ijms21228460","journal-title":"Int J Mol Sci"},{"issue":"2","key":"12634_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","volume":"35","author":"H Kafali","year":"2004","unstructured":"Kafali H, Iriadam M, Ozardal\u0131 I, Demir N (2004) Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res 35(2):103\u2013108. https:\/\/doi.org\/10.1016\/j.arcmed.2003.10.005","journal-title":"Arch Med Res"},{"issue":"4","key":"12634_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0278-5846(03)00045-9","volume":"27","author":"DC Lagace","year":"2003","unstructured":"Lagace DC, Nachtigal MW (2003) Valproic acid fails to induce polycystic ovary syndrome in female rats. Prog Neuropsychopharmacol Biol Psychiatry 27(4):587\u2013594. https:\/\/doi.org\/10.1016\/S0278-5846(03)00045-9","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"12634_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00025","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2020.00025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"12634_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12634_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102884","volume":"77","author":"Y Yang","year":"2024","unstructured":"Yang Y, Cheng J, Liu C, Zhang X, Ma N, Zhou Z et al (2024) Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data. EClinicalMedicine 77:102884. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102884","journal-title":"EClinicalMedicine"},{"issue":"2","key":"12634_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ph16020197","volume":"16","author":"L Corrie","year":"2023","unstructured":"Corrie L, Awasthi A, Kaur J, Vishwas S, Gulati M, Kaur IP et al (2023) Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies. Pharmaceuticals 16(2):197. https:\/\/doi.org\/10.3390\/ph16020197","journal-title":"Pharmaceuticals"},{"key":"12634_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1897212","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C (2021) The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2021.1897212","journal-title":"Gut Microbes"},{"key":"12634_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.806331","author":"X Wang","year":"2022","unstructured":"Wang X, Xu T, Liu R, Wu G, Gu L, Zhang Y et al (2022) High-fiber diet or combined with acarbose alleviates heterogeneous phenotypes of polycystic ovary syndrome by regulating gut microbiota. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.806331","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12634_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1604302","author":"X Feng","year":"2025","unstructured":"Feng X, Xiao J, Wang D, Fu X, Gao J, Jiang M et al (2025) Butyric acid ameliorates PCOS-related reproductive dysfunction through gut-brain-ovary axis signaling and ovarian steroidogenic factor activation. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2025.1604302","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12634_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.933110","author":"M Zhang","year":"2022","unstructured":"Zhang M, Hu R, Huang Y, Zhou F, Li F, Liu Z et al (2022) Present and future: crosstalks between polycystic ovary syndrome and gut metabolites relating to gut microbiota. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2022.933110","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1\u20132","key":"12634_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0303-7207(94)90278-X","volume":"100","author":"SG Hillier","year":"1994","unstructured":"Hillier SG, Whitelaw PF, Smyth CD (1994) Follicular oestrogen synthesis: the \u2018two-cell, two-gonadotrophin\u2019 model revisited. Mol Cell Endocrinol 100(1\u20132):51\u201354. https:\/\/doi.org\/10.1016\/0303-7207(94)90278-X","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"12634_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ (2011) The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocr Rev 32(1):81\u2013151. https:\/\/doi.org\/10.1210\/er.2010-0013","journal-title":"Endocr Rev"},{"issue":"9","key":"12634_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","volume":"15","author":"RJ Auchus","year":"2004","unstructured":"Auchus RJ (2004) The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metabolism 15(9):432\u2013438. https:\/\/doi.org\/10.1016\/j.tem.2004.09.004","journal-title":"Trends Endocrinol Metabolism"},{"key":"12634_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12487","author":"M Harada","year":"2022","unstructured":"Harada M (2022) Pathophysiology of polycystic ovary syndrome revisited: current understanding and perspectives regarding future research. Reprod Med Biol. https:\/\/doi.org\/10.1002\/rmb2.12487","journal-title":"Reprod Med Biol"},{"issue":"1","key":"12634_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.0.1740001","volume":"174","author":"D Abbott","year":"2002","unstructured":"Abbott D, Dumesic D, Franks S (2002) Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174(1):1\u20135. https:\/\/doi.org\/10.1677\/joe.0.1740001","journal-title":"J Endocrinol"},{"issue":"11","key":"12634_CR37","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1210\/jc.2013-2040","volume":"98","author":"A Dunaif","year":"2013","unstructured":"Dunaif A, Fauser BCJM (2013) Renaming PCOS\u2014A Two-State Solution. J Clin Endocrinol Metab 98(11):4325\u20134328. https:\/\/doi.org\/10.1210\/jc.2013-2040","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"12634_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.17219\/acem\/59380","volume":"26","author":"S Bednarska","year":"2017","unstructured":"Bednarska S, Siejka A (2017) The pathogenesis and treatment of polycystic ovary syndrome: what\u2019s new? Adv Clin Exp Med 26(2):359\u201367. https:\/\/doi.org\/10.17219\/acem\/59380","journal-title":"Adv Clin Exp Med"},{"issue":"6","key":"12634_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocr Rev 33(6):981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"issue":"5","key":"12634_CR40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"T Li","year":"2017","unstructured":"Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J et al (2017) Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome. Reproductive Sci 24(5):646\u2013655. https:\/\/doi.org\/10.1177\/1933719116667606","journal-title":"Reproductive Sci"},{"issue":"3","key":"12634_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cen.12086","volume":"78","author":"IR Wallace","year":"2013","unstructured":"Wallace IR, McKinley MC, Bell PM, Hunter SJ (2013) Sex hormone binding globulin and insulin resistance. Clin Endocrinol (Oxf) 78(3):321\u2013329. https:\/\/doi.org\/10.1111\/cen.12086","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"13","key":"12634_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136439","volume":"26","author":"E Deer","year":"2025","unstructured":"Deer E, LaMarca B, Reckelhoff JF, Shawky NM, Edwards K (2025) The role of mitochondrial dysfunction and oxidative stress in women\u2019s reproductive disorders: implications for polycystic ovary syndrome and preeclampsia. Int J Mol Sci 26(13):6439. https:\/\/doi.org\/10.3390\/ijms26136439","journal-title":"Int J Mol Sci"},{"key":"12634_CR43","doi-asserted-by":"publisher","unstructured":"Mazloomi S, Sanoeei Farimani M, Tayebinia H, Karimi J, Amiri I, Abbasi E et al (2022) The association of mitochondrial translocator protein and voltage-dependent anion channel-1 in granulosa cells with estradiol levels and presence of immature follicles in polycystic ovary syndrome. J Reprod Infertil 11. https:\/\/doi.org\/10.18502\/jri.v23i3.10005","DOI":"10.18502\/jri.v23i3.10005"},{"key":"12634_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00452","author":"S Franks","year":"2018","unstructured":"Franks S, Hardy K (2018) Androgen action in the ovary. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2018.00452","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"12634_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-019-0657-6","volume":"11","author":"P Sagvekar","year":"2019","unstructured":"Sagvekar P, Kumar P, Mangoli V, Desai S, Mukherjee S (2019) DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome. Clin Epigenetics 11(1):61. https:\/\/doi.org\/10.1186\/s13148-019-0657-6","journal-title":"Clin Epigenetics"},{"issue":"4","key":"12634_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1210\/jc.2016-2645","volume":"102","author":"P Sagvekar","year":"2017","unstructured":"Sagvekar P, Mangoli V, Desai S, Patil A, Mukherjee S (2017) LINE1 CpG-DNA hypomethylation in granulosa cells and blood leukocytes is associated with PCOS and related traits. J Clin Endocrinol Metab 102(4):1396\u20131405. https:\/\/doi.org\/10.1210\/jc.2016-2645","journal-title":"J Clin Endocrinol Metab"},{"key":"12634_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.lfs.2018.05.052","volume":"207","author":"M Salehi Jahromi","year":"2018","unstructured":"Salehi Jahromi M, Hill JW, Ramezani Tehrani F, Zadeh-Vakili A (2018) Hypomethylation of specific CpG sites in the promoter region of steroidogeneic genes (GATA6 and StAR) in prenatally androgenized rats. Life Sci 207:105\u2013109. https:\/\/doi.org\/10.1016\/j.lfs.2018.05.052","journal-title":"Life Sci"},{"issue":"9","key":"12634_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","volume":"17","author":"E Stener-Victorin","year":"2021","unstructured":"Stener-Victorin E, Deng Q (2021) Epigenetic inheritance of polycystic ovary syndrome \u2014 challenges and opportunities for treatment. Nat Rev Endocrinol 17(9):521\u2013533. https:\/\/doi.org\/10.1038\/s41574-021-00517-x","journal-title":"Nat Rev Endocrinol"},{"key":"12634_CR49","doi-asserted-by":"publisher","unstructured":"Blair RA, Neves JS, Nicklas JM, Skurnik G, Seely EW (2020) OR08-03 Association of Hemoglobin A1c with Early Postpartum Metabolic Syndrome in Women with Gestational Diabetes. J Endocr Soc 4(Supplement1). https:\/\/doi.org\/10.1210\/jendso\/bvaa046.857","DOI":"10.1210\/jendso\/bvaa046.857"},{"issue":"5","key":"12634_CR50","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","volume":"21","author":"N Naderpoor","year":"2015","unstructured":"Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ (2015) Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update 21(5):560\u201374. https:\/\/doi.org\/10.1093\/humupd\/dmv025","journal-title":"Hum Reprod Update"},{"issue":"14","key":"12634_CR51","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMc1610000","volume":"375","author":"CRMJC McCartney","year":"2016","unstructured":"McCartney CRMJC (2016) Polycystic Ovary Syndrome. N Engl J Med 375(14):1397\u20131399. https:\/\/doi.org\/10.1056\/NEJMc1610000","journal-title":"N Engl J Med"},{"issue":"11","key":"12634_CR52","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1210\/jcem.82.11.4377","volume":"82","author":"A Arroyo","year":"1997","unstructured":"Arroyo A, Laughlin GA, Morales AJ, Yen SSC (1997) Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity 1. J Clin Endocrinol Metab 82(11):3728\u201333. https:\/\/doi.org\/10.1210\/jcem.82.11.4377","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"12634_CR53","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y et al (2019) Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med 25(8):1225\u20131233. https:\/\/doi.org\/10.1038\/s41591-019-0509-0","journal-title":"Nat Med"},{"issue":"2","key":"12634_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz R (2018) Polycystic Ovary Syndrome. Obstet Gynecol 132(2):321\u2013336. https:\/\/doi.org\/10.1097\/AOG.0000000000002698","journal-title":"Obstet Gynecol"},{"key":"12634_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","volume":"145","author":"MO Goodarzi","year":"2015","unstructured":"Goodarzi MO, Carmina E, Azziz R (2015) DHEA, DHEAS and PCOS. J Steroid Biochem Mol Biol 145:213\u201325. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.06.003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"12634_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1514250","author":"Y Meng","year":"1990","unstructured":"Meng Y, Zhao T, Zhang R, Zhu X, Ma C, Shi Q (1990) Global burden of polycystic ovary syndrome among women of childbearing age, 1990\u20132021: a systematic analysis using the global burden of disease study 2021. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2025.1514250","journal-title":"Front Public Health"},{"issue":"1","key":"12634_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010174","volume":"12","author":"M Jozkowiak","year":"2022","unstructured":"Jozkowiak M, Piotrowska-Kempisty H, Kobylarek D, Gorska N, Mozdziak P, Kempisty B et al (2022) Endocrine disrupting chemicals in polycystic ovary syndrome: the relevant role of the theca and granulosa cells in the pathogenesis of the ovarian dysfunction. Cells 12(1):174. https:\/\/doi.org\/10.3390\/cells12010174","journal-title":"Cells"},{"issue":"11","key":"12634_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048963","volume":"7","author":"JK Wickenheisser","year":"2012","unstructured":"Wickenheisser JK, Biegler JM, Nelson-DeGrave VL, Legro RS, Strauss JF, McAllister JM (2012) Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome. PLoS One 7(11):e48963. https:\/\/doi.org\/10.1371\/journal.pone.0048963","journal-title":"PLoS One"},{"issue":"1","key":"12634_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40360-023-00692-9","volume":"24","author":"AAM Bashir","year":"2023","unstructured":"Bashir AAM, Olaniyi KS (2023) Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1. BMC Pharmacol Toxicol 24(1):48. https:\/\/doi.org\/10.1186\/s40360-023-00692-9","journal-title":"BMC Pharmacol Toxicol"},{"key":"12634_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-94-010-0163-2_13","volume-title":"Nuclear Factor \u043aB","author":"E Andreakos","year":"2003","unstructured":"Andreakos E, Udalova I, Sacre S, Foxwell BM (2003) The Role of NF-\u03baB in Inflammatory Diseases. Nuclear Factor \u043aB. Springer Netherlands, Dordrecht, pp 295\u2013323. https:\/\/doi.org\/10.1007\/978-94-010-0163-2_13"},{"issue":"3","key":"12634_CR61","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ram\u00edrez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19(3):268\u2013288. https:\/\/doi.org\/10.1093\/humupd\/dms059","journal-title":"Hum Reprod Update"},{"issue":"1","key":"12634_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-019-0273-8","volume":"16","author":"MA La Merrill","year":"2020","unstructured":"La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB et al (2020) Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol 16(1):45\u201357. https:\/\/doi.org\/10.1038\/s41574-019-0273-8","journal-title":"Nat Rev Endocrinol"},{"key":"12634_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109548","volume":"125","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zhou Z, Zhang G, Yang Z, Shi Y, Jiang Z et al (2024) Metabolome implies increased fatty acid utilization and histone methylation in the follicles from hyperandrogenic PCOS women. J Nutr Biochem 125:109548. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109548","journal-title":"J Nutr Biochem"},{"key":"12634_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mce.2015.07.002","volume":"414","author":"A Mehta","year":"2015","unstructured":"Mehta A, Ravinder, Onteru SK, Singh D (2015) HDAC inhibitor prevents LPS mediated inhibition of CYP19A1 expression and 17\u03b2-estradiol production in granulosa cells. Mol Cell Endocrinol 414:73\u201381. https:\/\/doi.org\/10.1016\/j.mce.2015.07.002","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"12634_CR65","first-page":"187","volume":"43","author":"J Liu","year":"2012","unstructured":"Liu J, Zhang D (2012) [The role of oxidative stress in the pathogenesis of polycystic ovary syndrome]. Sichuan Da Xue Xue Bao Yi Xue Ban 43(2):187\u2013190 PubMed PMID: 22650028","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"19","key":"12634_CR66","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","volume":"329","author":"J Isojarvi","year":"1993","unstructured":"Isojarvi J, Laatikainen TJ, Pakarinen AJ, Juntunen K, Myllyla VV (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329(19):1383\u20138. https:\/\/doi.org\/10.1056\/NEJM199311043291904","journal-title":"N Engl J Med"},{"issue":"1","key":"12634_CR67","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00580-025-03633-6","volume":"34","author":"KS Olaniyi","year":"2025","unstructured":"Olaniyi KS, Akintayo CO, Oladimeji TE, Areloegbe SE, Badejogbin OC, Bashir AAM et al (2025) Butyrate ameliorates ovarian failure in experimental PCOS rat model by suppression of HDAC2. Comp Clin Path 34(1):155\u2013167. https:\/\/doi.org\/10.1007\/s00580-025-03633-6","journal-title":"Comp Clin Path"},{"issue":"5","key":"12634_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/life15050762","volume":"15","author":"P Escorcia Mora","year":"2025","unstructured":"Escorcia Mora P, Valbuena D, Diez-Juan A (2025) The role of the gut microbiota in female reproductive and gynecological health: insights into endometrial signaling pathways. Life (Basel) 15(5):762. https:\/\/doi.org\/10.3390\/life15050762","journal-title":"Life (Basel)"},{"issue":"1","key":"12634_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW (2014) New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124(1):30\u201339. https:\/\/doi.org\/10.1172\/JCI69738","journal-title":"J Clin Invest"},{"issue":"1","key":"12634_CR70","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13048-025-01734-y","volume":"18","author":"KA Padder","year":"2025","unstructured":"Padder KA, Jahan N, Yousuf MA, Shah IA, Bhat GA, Khurshid R et al (2025) Deciphering the interplay between oxidative stress and inflammation in polycystic ovary syndrome: outcome of a case-control study. J Ovarian Res 18(1):196. https:\/\/doi.org\/10.1186\/s13048-025-01734-y","journal-title":"J Ovarian Res"},{"issue":"4","key":"12634_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.22074\/cellj.2022.7787","volume":"24","author":"Z Hashemain","year":"2022","unstructured":"Hashemain Z, Amiri-Yekta A, Khosravifar M, Alvandian F, Shahhosseini M, Hosseinkhani S et al (2022) CYP19A1 promoters activity in human granulosa cells: a comparison between PCOS and normal subjects. Cell J 24(4):170\u20135. https:\/\/doi.org\/10.22074\/cellj.2022.7787","journal-title":"Cell J"},{"issue":"8","key":"12634_CR72","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00109-012-0881-4","volume":"90","author":"F Qu","year":"2012","unstructured":"Qu F, Wang FF, Yin R, Ding GL, El-prince M, Gao Q et al (2012) A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med 90(8):911\u2013923. https:\/\/doi.org\/10.1007\/s00109-012-0881-4","journal-title":"J Mol Med"},{"issue":"6","key":"12634_CR73","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4161\/epi.3.6.7273","volume":"3","author":"A Abbas","year":"2008","unstructured":"Abbas A, Gupta S (2008) The role of histone deacetylases in prostate cancer. Epigenetics 3(6):300\u2013309. https:\/\/doi.org\/10.4161\/epi.3.6.7273","journal-title":"Epigenetics"},{"issue":"1","key":"12634_CR74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13148-016-0293-3","volume":"8","author":"C Sathishkumar","year":"2016","unstructured":"Sathishkumar C, Prabu P, Balakumar M, Lenin R, Prabhu D, Anjana RM et al (2016) Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes. Clin Epigenetics 8(1):125. https:\/\/doi.org\/10.1186\/s13148-016-0293-3","journal-title":"Clin Epigenetics"},{"key":"12634_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.72.e146759","volume":"72","author":"M Moneva-Sakelarieva","year":"2025","unstructured":"Moneva-Sakelarieva M, Kobakova Y, Konstantinov S, Momekov G, Ivanova S, Atanasova V et al (2025) The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities. Pharmacia 72:1\u201313. https:\/\/doi.org\/10.3897\/pharmacia.72.e146759","journal-title":"Pharmacia"},{"key":"12634_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1722649","author":"Y Chen","year":"2026","unstructured":"Chen Y, Sun X, Xia X, Chen K, Zeng F (2026) The pathogenesis, therapeutic targets and drugs of polycystic ovary syndrome. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2025.1722649","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"12634_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049553","volume":"7","author":"C Glister","year":"2012","unstructured":"Glister C, Satchell L, Michael AE, Bicknell AB, Knight PG (2012) The anti-epileptic drug valproic acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro. PLoS One 7(11):e49553. https:\/\/doi.org\/10.1371\/journal.pone.0049553","journal-title":"PLoS One"},{"issue":"7","key":"12634_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272124","volume":"17","author":"KS Olaniyi","year":"2022","unstructured":"Olaniyi KS, Bashir A, Areloegbe SE, Sabinari IW, Akintayo CO, Oniyide AA et al (2022) Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model. PLoS One 17(7):e0272124. https:\/\/doi.org\/10.1371\/journal.pone.0272124","journal-title":"PLoS One"},{"issue":"4","key":"12634_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000203537","volume":"67","author":"H Gorkemli","year":"2009","unstructured":"Gorkemli H, Genc BO, Dogan EA, Genc E, Ozdemir S (2009) Long-term effects of valproic acid on reproductive endocrine functions in turkish women with epilepsy. Gynecol Obstet Invest 67(4):223\u2013227. https:\/\/doi.org\/10.1159\/000203537","journal-title":"Gynecol Obstet Invest"},{"issue":"7","key":"12634_CR80","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/j.1528-1167.2007.01100.x","volume":"48","author":"S Prabhakar","year":"2007","unstructured":"Prabhakar S, Sahota P, Kharbanda PS, Siali R, Jain V, Lal V et al (2007) Sodium valproate, hyperandrogenism and altered ovarian function in indian women with epilepsy: a prospective study. Epilepsia 48(7):1371\u20131377. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01100.x","journal-title":"Epilepsia"},{"issue":"11","key":"12634_CR81","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.biopsych.2005.10.017","volume":"59","author":"H Joffe","year":"2006","unstructured":"Joffe H, Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM et al (2006) Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry 59(11):1078\u20131086. https:\/\/doi.org\/10.1016\/j.biopsych.2005.10.017","journal-title":"Biol Psychiatry"},{"key":"12634_CR82","doi-asserted-by":"crossref","unstructured":"Ribacoba Montero R, Mart\u00ednez-Faedo C, Salas-Puig J (2003) Polycystic ovary syndrome and valproic acid. Rev Neurol 37(10):975\u2013982. PubMed PMID: 14634930.","DOI":"10.33588\/rn.3710.2002615"},{"issue":"12","key":"12634_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121605","volume":"14","author":"MA Theodoropoulou","year":"2024","unstructured":"Theodoropoulou MA, Mantzourani C, Kokotos G (2024) Histone deacetylase (HDAC) inhibitors as a novel therapeutic option against fibrotic and inflammatory diseases. Biomolecules 14(12):1605. https:\/\/doi.org\/10.3390\/biom14121605","journal-title":"Biomolecules"},{"issue":"10","key":"12634_CR84","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1016\/S0021-9258(17)34804-4","volume":"253","author":"LC Boffa","year":"1978","unstructured":"Boffa LC, Vidali G, Mann RS, Allfrey VG (1978) Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 253(10):3364\u20136","journal-title":"J Biol Chem"},{"key":"12634_CR85","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw8429","author":"I Kimura","year":"1979","unstructured":"Kimura I, Miyamoto J, Ohue-Kitano R, Watanabe K, Yamada T, Onuki M et al (1979) Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science. https:\/\/doi.org\/10.1126\/science.aaw8429","journal-title":"Science"},{"key":"12634_CR86","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000444R","author":"Q Ye","year":"2021","unstructured":"Ye Q, Zeng X, Wang S, Zeng X, Yang G, Ye C et al (2021) Butyrate drives the acetylation of histone H3K9 to activate steroidogenesis through PPAR\u03b3 and PGC1\u03b1 pathways in ovarian granulosa cells. FASEB J. https:\/\/doi.org\/10.1096\/fj.202000444R","journal-title":"FASEB J"},{"issue":"4","key":"12634_CR87","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s12602-018-9493-9","volume":"11","author":"J Heshmati","year":"2019","unstructured":"Heshmati J, Farsi F, Yosaee S, Razavi M, Rezaeinejad M, Karimie E et al (2019) The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials. Probiotics Antimicrob Proteins 11(4):1236\u20131247. https:\/\/doi.org\/10.1007\/s12602-018-9493-9","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"12634_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62951-z","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wu J, Zhang G, Shi Y, Meng Y, Lv P et al (2025) Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome. Nat Commun 16(1):7611. https:\/\/doi.org\/10.1038\/s41467-025-62951-z","journal-title":"Nat Commun"},{"issue":"5","key":"12634_CR89","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s12602-024-10223-5","volume":"16","author":"S Salehi","year":"2024","unstructured":"Salehi S, Allahverdy J, Pourjafar H, Sarabandi K, Jafari SM (2024) Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy. Probiotics Antimicrob Proteins 16(5):1553\u20131565. https:\/\/doi.org\/10.1007\/s12602-024-10223-5","journal-title":"Probiotics Antimicrob Proteins"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12634-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T18:02:19Z","timestamp":1787335339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12634-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12634"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12634-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This manuscript is a narrative review and does not involve human participants, animal subjects, or clinical data requiring ethical approval.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1438"}}